125 related articles for article (PubMed ID: 10750667)
1. Definition of tumor-associated antigens in hepatocellular carcinoma.
Stenner-Liewen F; Luo G; Sahin U; Tureci O; Koslovski M; Kautz I; Liewen H; Pfreundschuh M
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):285-90. PubMed ID: 10750667
[TBL] [Abstract][Full Text] [Related]
2. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.
Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR
Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486
[TBL] [Abstract][Full Text] [Related]
3. Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma.
Uemura M; Nouso K; Kobayashi Y; Tanaka H; Nakamura S; Higashi T; Ono T; Nakayama E; Hanafusa T; Shiratori Y
Cancer; 2003 May; 97(10):2474-9. PubMed ID: 12733146
[TBL] [Abstract][Full Text] [Related]
4. Identification of tumor-associated antigens in human hepatocellular carcinoma by autoantibodies.
Chen X; Fu S; Chen F; Chen H; Chen Z
Oncol Rep; 2008 Oct; 20(4):979-85. PubMed ID: 18813843
[TBL] [Abstract][Full Text] [Related]
5. Multiple variants and a differential splicing pattern of kinectin in human hepatocellular carcinoma.
Wang HC; Su YR; Han KJ; Pang XW; Peng JR; Liang B; Wang S; Chen WF
Biochem Cell Biol; 2004 Apr; 82(2):321-7. PubMed ID: 15060627
[TBL] [Abstract][Full Text] [Related]
6. Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma.
Wang K; Xu X; Nie Y; Dai L; Wang P; Zhang J
Cancer Lett; 2009 Aug; 281(2):144-50. PubMed ID: 19304375
[TBL] [Abstract][Full Text] [Related]
7. [Screening and analysis of genes encoding hepatocellular carcinoma associated tumor antigens].
Wang HC; Yang MH; Shi YY; Pang XW; Yang XA; Peng JR; Leng XS; Chen WF
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):343-6. PubMed ID: 15918967
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
9. [Human esophageal carcinoma antigens screened by serologic analysis of recombinant cDNA expression libraries (SEREX)].
Yu L; Hu H; Ran YL; Peng LP; Li JW; Yang ZH
Ai Zheng; 2007 Jan; 26(1):100-5. PubMed ID: 17222377
[TBL] [Abstract][Full Text] [Related]
10. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
[TBL] [Abstract][Full Text] [Related]
11. [Melanoma antigen-3 expression in human hepatocellular carcinoma].
Cai S; Zhao H; Leng X; Cheng J; Gong S; Peng J; Cong X; Wang Y; Rui J; Hui Y; Du R; Chen W
Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):693-6. PubMed ID: 11832142
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.
Korangy F; Ormandy LA; Bleck JS; Klempnauer J; Wilkens L; Manns MP; Greten TF
Clin Cancer Res; 2004 Jul; 10(13):4332-41. PubMed ID: 15240519
[TBL] [Abstract][Full Text] [Related]
13. Significant increase in the antibody to Gal alpha 1-3Gal structure in sera of patients with hepatocellular carcinoma after transcatheter arterial embolization.
Kashiwagi M; Ikeda Y; Iwamori M; Toda G; Nagai Y
Cancer Res; 1989 Aug; 49(16):4396-401. PubMed ID: 2545342
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma.
Mizukoshi E; Nakamoto Y; Marukawa Y; Arai K; Yamashita T; Tsuji H; Kuzushima K; Takiguchi M; Kaneko S
Hepatology; 2006 Jun; 43(6):1284-94. PubMed ID: 16729333
[TBL] [Abstract][Full Text] [Related]
15. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
16. Expression of the MAGE-1 gene in human hepatocellular carcinomas.
Chen H; Cai S; Wang Y; Zhao H; Peng J; Pang X; Zhu J; Cong X; Rui J; Leng X; Du R; Wang Y; Vaughan H; Cebon J; Burgess AW; Chen W
Chin Med J (Engl); 2000 Dec; 113(12):1112-8. PubMed ID: 11776148
[TBL] [Abstract][Full Text] [Related]
17. Analysis of differentially expressed genes in hepatocellular carcinoma with hepatitis C virus by suppression subtractive hybridization.
Kotaka M; Chen GG; Lai PB; Lau WY; Chan PK; Leung TW; Li AK
Oncol Res; 2002; 13(3):161-7. PubMed ID: 12549625
[TBL] [Abstract][Full Text] [Related]
18. [Screening and identification for cDNA of differentially expressed genes in human primary hepatocellular carcinoma].
Li J; Han BL; Huang GJ; Qian GS; Liang P; Yang TH; Chen J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):49-52. PubMed ID: 12579501
[TBL] [Abstract][Full Text] [Related]
19. LFIRE-1/HFREP-1, a liver-specific gene, is frequently downregulated and has growth suppressor activity in hepatocellular carcinoma.
Yan J; Yu Y; Wang N; Chang Y; Ying H; Liu W; He J; Li S; Jiang W; Li Y; Liu H; Wang H; Xu Y
Oncogene; 2004 Mar; 23(10):1939-49. PubMed ID: 14981537
[TBL] [Abstract][Full Text] [Related]
20. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]